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Background: Commercial wrist-worn activity monitors have the potential to accurately assess activity
levels and are being increasingly adopted in the general population. The aim of this study was to
determine if feedback from a commercial activity monitor improves activity levels over the ﬁrst 6 weeks
after total hip arthroplasty (THA) or total knee arthroplasty (TKA).
Methods: One hundred sixty-three consecutive subjects undergoing primary TKA or THA were randomized
into 2 groups. Subjects received an activity tracker with the step display obscured 2 weeks before surgery
and completed patient-reported outcome measures (PROMs). On day 1 after surgery, participants were
randomized to either the “feedback (FB) group” or the “no feedback (NFB) group.” The FB group was able to
view their daily step count and was given a daily step goal. Participants in the NFB group wore the device
with the display obscured for 2 weeks after surgery, after which time they were also able to see their daily
step count but did not receive a formal step goal. The mean daily steps at 1, 2, 6 weeks, and 6 months were
monitored. At 6 months after surgery, subjects repeated PROMs and daily step count collection.
Results: Of the 163 subjects, 95 underwent THA and 68 underwent TKA. FB subjects had a signiﬁcantly
higher (P < .03) mean daily step count by 43% in week 1, 33% in week 2, 21% in week 6, and 17% at 6
months, compared with NFB. The FB subjects were 1.7 times more likely to achieve a mean 7000 steps
per day than the NFB subjects at 6 weeks after surgery (P ¼ .02). There was no signiﬁcant difference
between the groups in PROMs at 6 months. Ninety percent of FB and 83% of NFB participants reported
that they were satisﬁed with the results of the surgery (P ¼ .08). At 6 months after surgery, 70% of
subjects had a greater mean daily step count compared with their preoperative level.
Conclusion: Subjects who received feedback from a commercial activity tracker with a daily step goal had
signiﬁcantly higher activity levels after hip and knee arthroplasty over 6 weeks and 6 months, compared
with subjects who did not receive feedback in a randomized controlled trial. Commercial activity trackers
may be a useful and effective adjunct after arthroplasty.
© 2018 Elsevier Inc. All rights reserved.
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Mobility and physical activity are imperative to healthy aging.
Evidence supports the positive beneﬁts of regular physical activity
with higher activity being associated with reduction in the risk of
No author associated with this paper has disclosed any potential or pertinent
conﬂicts which may be perceived to have impending conﬂict with this work. For
full disclosure statements refer to https://doi.org/10.1016/j.arth.2018.06.024.
* Reprint requests: Lucy J. Salmon, North Sydney Orthopaedic and Sports Medicine Centre, Mater Clinic, Suite 2, 3 Gillies Street Wollstonecraft, Sydney, NSW 2065,
Australia.
https://doi.org/10.1016/j.arth.2018.06.024
0883-5403/© 2018 Elsevier Inc. All rights reserved.

chronic disease and premature mortality [1,2]. More recently, associations such as the Committee on Exercise and Cardiac Rehabilitation of the American Heart Association endorse regular
physical activity and even classify it as a modiﬁable risk factor for
prevention from cardiovascular diseases and other chronic diseases, including diabetes mellitus, cancer, obesity, hypertension,
bone and joint diseases, and depression [3].
After joint arthroplasty, the aim should, therefore, be not only to
improve pain and function but also to improve activity. This activity
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should preferably meet the recommended daily activity levels as recommended by the World Health Organization (WHO), US Center for
Disease Control, and the National Heart Foundation of Australia [4,5].
Historically, postoperative activity has been monitored using
participant-completed subjective questionnaires [6,7]. However,
reports in literature have questioned the accuracy and validity of
this form of assessment. It has been identiﬁed that in selfassessment of physical activity, people tend to overestimate their
level of activity by as much as 50% [5]. Verlaan et al [8] reported that
up to 62% of the general population met the activity intensity
guidelines according to their self-assessment questionnaire,
whereas only 9.6% met these same guidelines, when deﬁned from
objective physical activity monitoring.
With the recent development of commercial-based accelerometers (activity trackers), the “subjective” error has been decreased,
and it has become easier to accurately measure daily activity level.
It has also been identiﬁed that these activity trackers have a great
potential to accurately assess activity level before and after joint
arthroplasty [9]. These devices are largely used in the ﬁtness industry as a motivational tool for those wanting to monitor and
improve ﬁtness. More importantly, these devices have been shown
to be a valid and reliable assessment tool for activity levels in
normal participants [10] and participants after cardiac surgery [11].
In this study, we used commercial activity trackers to monitor and
encourage higher activity levels in a series of participants before and
after total knee arthroplasty (TKA) or total hip arthroplasty (THA).

Table 1
Daily Step Goal Given to Subjects in the Feedback Group.
Postop Day

Daily Step Goal

Day 1
Day 2
Day 3
Day 4
Days 5-7
Week 2
Week 3
Week 4
Week 5
Week 6

No goal
500
1000
1500
2000
3000
4000
5000
6000
7000

Our hypothesis was that subjects who received feedback of step
count in the ﬁrst 2 weeks after surgery would have higher mean
daily step count over the ﬁrst 6 weeks after TKA or THA. We also
examined whether this impacted participant satisfaction,
participant-reported outcome measures, or 6-month activity level.
Materials and Methods
This was a single-center parallel group randomized controlled
study with an equal allocation ratio. Eligible patients were all adults
undergoing primary elective hip or knee arthroplasty under the
care of one of the investigating surgeons between May 2016 and

Fig. 1. Participant ﬂowchart according to the CONSORT guidelines.
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December 2016. Patients were required to provide written
informed consent and were randomized to either control (no
feedback [NFB]) group or device feedback (FB) group. Subjects with
rheumatoid arthritis or other inﬂammatory diseases and those
undergoing hip arthroplasty after an acute femoral fracture were
excluded. Subjects who were not contactable within 2 weeks of
their surgery were excluded.
Two weeks before surgery, subjects were contacted via telephone and were invited to participate. All potential participants
were informed the purpose of the study. Participants were emailed
or posted the written Participant Information and Consent Form as
approved by the Hospitals Human Research Ethics Committee. If
the participant consented, they received a Garmin Vivoﬁt 2 device
for 2 weeks before their surgery. The Garmin Vivoﬁt 2 uses a 3-axis
Micro-ElectroMechanical Systems accelerometer to estimate step
count. This device has a long battery life of roughly 12 months, and
the retail cost is AUD$109. The device has been shown to be valid
and reliable for assessment of step count [12e14].
The display on the Vívoﬁt 2 device, which indicates the number
of steps per day, was obscured from all participants in the preoperative period. On day 1 after arthroplasty, randomization was
performed. The randomization was blocked in multitudes of 40
with a 1:1 allocation ratio. The random permutation list was
generated from http://www.randomization.com. From this list, a
series of 40 numbered and sealed envelopes were created with the
words “Feedback Group” or “No Feedback Group” generated in the
order determined by the permutation list. When a participant was
to be randomized, the researcher obtained the next sequentially
numbered envelope from a contact who was independent of the
recruitment process for allocation consignment.
A researcher visited the subject on the ﬁrst day after surgery and
advised as to which group they had been allocated. If the subject
was in the “FB group” the cover over the Vivoﬁt display was
removed to make the step count visible and he or she was given a
daily step goal as indicated in Table 1. Subjects were advised that
this goal should be considered a rough guide based on average
activity level after arthroplasty and may need to be adjusted in
some circumstances for medical or lifestyle reasons. The weekly
step goal was selected based on the mean daily steps observed in a
previous study of subjects with activity monitors after arthroplasty
[15]. The goal of 7000 steps by week 6 was selected, as this is the
recommended daily step count for healthy older adults (>65) [16].
Participants in the “NFB group” continued to wear the device
with the display obscured for 2 weeks after surgery and were not
given a daily step goal.
The mean daily steps from each group for the ﬁrst 2 weeks was
recorded and compared. After 2 weeks, all participants were
permitted to remove the cover over the display and see the step
count. The nonrandomized group was not given the login or
password required to sync the device and therefore could not access their data until after they were unblinded. All participants
from both groups continued to wear their device until 6 weeks after
surgery. Where possible, the Garmin Vivoﬁt 2 device was synced to
the subject's mobile device (phone or tablet) using the Garmin
Connect mobile application. If the subject did not have a suitable
mobile device, arrangements were made for the device to be
synced at least every 3 weeks with the research unit's computers,
either in person or via post. At 6 weeks after surgery, participants
returned the Garmin Vívoﬁt 2 in person or via post. At 6 months
after surgery, subjects wore the Garmin Vívoﬁt 2 again for a period
of 3 weeks.
All subjects completed patient-reported outcome measures
(PROMs) preoperatively and at 6 months after surgery. The questionnaire included the disease-speciﬁc measure of the Knee Injury
and Osteoarthritis Outcome Score or Hip Disability and
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Osteoarthritis Outcome Score, and the general measure of the
EuroQol-5D: an instrument for measuring quality of life. At 6
months, patients also completed the satisfaction component of the
Knee Society Score and graded their satisfaction with their outcome
of surgery on a 5-point scale from very satisﬁed to very disappointed. They were also asked if they would have the same surgery
again under the same circumstances (yes/no/unsure).
The study was performed at the Mater Hospital, a private hospital located in Sydney, Australia, where over 2000 arthroplasty
procedures are performed annually. The routine care of subjects
undergoing arthroplasty included admission on the day of surgery,
5-day postoperative stay in acute care orthopedic ward,
commencement of mobilization on day 1 after surgery, and twicedaily physiotherapy sessions for 5 days. The vast majority of subjects then attend inpatient rehabilitation for a further 7-10 days and
outpatient sessions twice a week until 6 weeks from surgery.
The study was initially designed to recruit 300 participants.
Before the commencement of the study, a series of 30 participants
undergoing TKA wore a Garmin Activity monitor for 6 weeks after
surgery. In this population, the mean number of recorded steps
per day was 6700 (standard deviation 3200) before surgery and
5700 at 6 weeks (standard deviation 2600). These data were used
to determine the study sample size for the randomised controlled
trial
design.
Power
calculations
(from
http://www.
statisticalsolutions.net/) determined that to detect a 25% variation in mean step count, with a power of 0.8 and a signiﬁcance
level of 0.05, 113 participants were required for each group. By
oversampling an additional 37 participants in each group, we
account for potential withdrawals and loss to follow-up. A single
planned interim analysis of the primary outcome measures was
performed 7 months after commencement of the study, after
recruitment of over 200 subjects. A statistically signiﬁcant difference between the FB and NFB groups was evident on all primary outcome measures of 1-, 2-, and 6-week step count;
therefore, recruitment was ceased after the enrollment of 202
subjects.

Table 2
Baseline Demographic and Clinical Characteristics of the Feedback and No Feedback
Groups.
Demographic and Baseline
Clinical Characteristics
Op type
THA
TKA
Gender
Male
Side
Right
Age
BMI
Preop mean daily step count
Preop patient-reported scores
KOOS
Symptoms
Pain
Function
QoL
EQ-5D
Mobility
Self-care
Usual activities
Pain
Anxiety/depression
General health

Feedback Group
(N ¼ 81)

No Feedback Group
(N ¼ 82)

P

52 (64%)
29 (36%)

43 (53%)
39 (48%)

.128

45 (56%)

36 (44%)

.137

48 (59%)
67 (9)
27.8 (4.5)
6953

53 (65%)
66 (9)
28.2 (4.1)
7655

.480
.289
.951
.146

45
47
50
30

(18)
(16)
(18)
(19)

45
45
51
33

(18)
(19)
(21)
(18)

.849
.443
.794
.335

2.8
1.5
2.6
3.2
1.6
71

(0.9)
(0.8)
(1.0)
(0.9)
(0.9)
(18)

2.7
1.4
2.4
3.3
1.6
72

(0.9)
(0.8)
(0.9)
(0.6)
(0.8)
(16)

.461
.426
.201
.591
.677
.786

Data are expressed as means (standard deviation) or numbers (%).
BMI, body mass index; KOOS, Knee Injury and Osteoarthritis Outcome Score; THA,
total hip arthroplasty; TKA, total knee arthroplasty; QoL, Quality of Life.
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Table 3
Mean Daily Step Count Expressed as Percentage of Preoperative Step Count for the Feedback and No Feedback Groups.
Mean Daily
Step Count

Feedback Group
(N ¼ 81) (%)

No Feedback Group
(N ¼ 82) (%)

P Value

Ratio

Mean
Difference (%)

95% CI for the
Mean Difference (%)

Cohen's d

1
2
6
6

20
44
103
137

14
33
85
117

.002
.001
.005
.030

1.43
1.33
1.21
1.17

6
11
18
20

2-10
5-18
6-31
2-38

0.5
0.5
0.5
0.4

wk
wk
wk
mo

CI, conﬁdence interval.

Statistical Methods
The primary end point of the study was the average daily step
count as measured using the Garmin Vivoﬁt device at 1 week, 2
weeks, and 6 weeks after surgery. This was expressed as a percentage of the subject's preoperative step count. Secondary end
points were 6-month PROMs and mean daily step count. Continuous variables such as mean step count and patient-reported scores
were compared between treatment groups with independent t
tests. Changes over time were assessed using paired t tests. The
magnitude of mean differences between treatment groups were
assessed with Cohen's d. Difference in proportions of patients between treatment groups were assessed using the chi-square test
(c2 test). Fisher's exact test was used for comparing proportions
when the cell counts were less than 5. Risk ratios and 95% conﬁdence intervals were calculated for proportions as a risk estimate.

difference between the 2 groups for patient-reported outcome
scores at 6 months after surgery.
Patient satisfaction with the outcome was assessed at 6 months,
and the results are shown in Table 5. There was a trend (P ¼ .089)
toward higher proportion of satisﬁed or very satisﬁed subjects in
the FB group, compared with the NFB group.
Thirty-day readmission was monitored for all subjects. One
patient in the FB group was readmitted with a postoperative wound
dehiscence at 17 days postoperatively and underwent debridement
of the surgical wound and administration of intravenous antibiotics
for 5 days. Tissue culture returned positive for Staphylococcus epidermidis. No further treatment was necessary. One patient in the
NFB group was readmitted after 28 days for investigation of pyrexia
of unknown origin. No treatment was required.

Discussion
Results
Between May 2016 and December 2016, 395 subjects underwent
primary hip or knee arthroplasty under the care of the investigating
surgeons. Participant ﬂowchart is shown according to the Consolidated Standards of Reporting Trials (CONSORT) guidelines in Figure 1.
Two hundred two subjects met the eligibility criteria and were
enrolled in the study; 9 patients were excluded as their surgery was
canceled or postponed and 30 patients were excluded as there were
insufﬁcient data for baseline step count. The ﬁnal groups included 81
subjects in the FB group and 82 subjects in the NFB group.
Baseline demographic and clinical characteristics of the 2
groups are shown in Table 2. There were no signiﬁcant differences
between the FB and NFB groups for any of the baseline variables or
characteristics. Daily step count was recorded for each subject as a
mean of 36 of a possible 42 days in the ﬁrst 6 weeks after surgery.
Days missing step counts was either due to noncompliance with
wearing the device or difﬁculties in successfully syncing the device
to retrieve step counts.
Mean daily step count for the 2 groups at 1 week, 2 weeks, 6
weeks, and 6 months is shown in Table 3 and Figure 2. The FB group
had a signiﬁcantly higher mean step count at all review points than
the NFB group. Cohen's d was 0.4-0.5, indicating a moderate effect
size [17]. The mean difference between groups ranged from 6% to
20% between 1 week and 6 months after surgery. For the FB group,
the mean daily step count increased from 7069 preoperatively to
8326 at 6 months after surgery (P ¼ .001). For the NFB group, the
mean daily step count increased from 7748 preoperatively to 8467
at 6 months after surgery (P ¼ .001).
Seven thousand steps per day is recommended as a suitable
activity level for subjects over 65 years [16]. The proportion of
subjects achieving a mean of 7000 or more steps each day is shown
in Figure 3. Subjects in the FB group were 1.7 (95% conﬁdence interval 1.2-2.6) more likely to be achieve a mean 7000 steps per day
than subjects in the NFB group at 6 weeks after surgery (P ¼ .02).
The patient-reported outcome scores reported at 6 months for
the 2 groups are shown in Table 4. There was no signiﬁcant

Subjects who received feedback from a commercial activity
tracker with a daily step goal had signiﬁcantly higher activity levels
after hip and knee arthroplasty at all measured time points over 6
months, compared with subjects who did not receive feedback.
Feedback from activity trackers was found to be an effective tool for
increasing early mobilization, with subjects being motivated to
“achieve their daily goal”.
This study is the ﬁrst to report the positive effect of the use of
activity monitors after knee and hip arthroplasty. Our results
indicated that in the FB group, the patients receiving a daily goal
and daily feedback in the ﬁrst 2 weeks after surgery led to increased
activity in the acute phase, increased activity at 6 months, and a
trend to improved higher patient satisfaction at 6 months (P ¼ .09).
The FB group had signiﬁcantly higher activity than the NFB group
by 45% at 1 week, 34% at 2 weeks, 26% at 6 weeks, and then ﬁnally
17% at 6-month mark. With the evident beneﬁts of physical activity
to healthy aging, especially after surgery, this increased activity can
be considered a positive effect for a successful surgery.

Fig. 2. Mean step count as a percentage of preoperative steps in the feedback and no
feedback groups over time.
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Fig. 3. Proportion of subjects in the feedback and no feedback groups taking a mean 7000 or more steps each day over time.

The success after joint arthroplasty can be measured by a variety of parameters. It is important to aim to improve not only pain
and function but also physical activity. Physical activity includes
an improvement in mobility which can be measured by daily step
count. However, until now, a reliable objective measure of
improved step count after arthroplasty has not been reported. The
WHO, US Center for Disease Control, and the National Heart
Foundation of Australia have released a list of recommendations
of daily activity or step count to improve an individuals' health
and reduce the risk of disease. According to their recommendations, an average individual needs to take 10,000 steps a day to
improve their health and reduce the risk of disease [18e20]. It is
further speciﬁed that the recommended daily step count for
healthy older adults (>65 years) is 7000-10,000 [21]. The proportion of subjects taking 7000 steps or more increased from 50%
before surgery to 70% at 6 months after surgery. The mean daily
step count at 6 months was increased compared with preoperative status in 66% of the subjects. Even though a value of 10,000
steps/day currently is promoted as a target for obtaining health
beneﬁts, the increase seen in these patients after arthroplasty can
be seen as a step in the right direction toward improving their
health outcomes.
It should be noted that the groups were differentiated by the
presence or absence of feedback from the activity monitor only for

Table 4
Patient-Reported Outcome Scores for the 2 Groups at 6 Mo.
Patient-Reported Scores
KOOS, mean (SD)
Symptoms/100
Pain/100
Function/100
QoL/100
EQ-5D, mean (SD)
Mobility/5
Self-care/5
Usual activities/5
Pain/5
Anxiety/depression/5
General health/10

Feedback Group
(N ¼ 80)

No Feedback Group
(N ¼ 82)

P

75.6
86.0
87.3
75.5

(21.2)
(13.8)
(10.2)
(17.2)

75.1
85.4
86.4
74.8

(19.2)
(15.3)
(13.7)
(20.0)

.886
.801
.651
.812

1.5
1.1
1.5
1.7
1.2
7.8

(0.8)
(0.6)
(0.8)
(0.8)
(0.6)
(1.9)

1.3
1.1
1.4
1.8
1.3
8.2

(0.7)
(0.3)
(0.6)
(0.7)
(0.6)
(1.6)

.176
.434
.435
.836
.529
.160

EQ-5D, EuroQol-5; KOOS, Knee Injury and Osteoarthritis Outcome Score; SD, standard deviation.

the ﬁrst 2 weeks after surgery. After this time, both groups were
able to see their daily step count on the device, but only the FB
group was encouraged to use the weekly step goals (see Table 1). It
is interesting that the early feedback from the device and the use a
goal had a positive effect over the full 6 months of the study. We
hypothesize that the early feedback was a powerful and persisting
motivator for subjects to be aware of their activity level over the
long term.
With the recent rise in technological based assessment tools, it
is important for the orthopedic fraternity to stay up to date [22]
According to the WHO, physical activity should be assessed by its
4 components: frequency, intensity, time, and the type of activity.
Modern commercially available activity trackers have the ability to
monitor all the frequency, intensity, time, and the type of activity
components. Physical performance is used as an assessment tool
for patient recovery, rehabilitation, and clinical progress postoperatively. It is, therefore, important to be able to measure this
accurately. The devices used in this study did not include a heart
rate monitor to assess intensity, rather we deliberately focused on
the daily step count, as it is our opinion that in the older population
group, simpler goals may just be more appropriate. There are
different forms of activity monitors with increasing levels of
complexity and accuracy but ultimately just a basic, accurate activity monitor proved to be valuable in the rehabilitation of the
patients who underwent joint arthroplasty.
Patient satisfaction is the ultimate indicator of successful surgery. At 6 months after surgery, 91% of subjects in the FB group
reported that they were satisﬁed or very satisﬁed with the outcome
of the surgery, compared with 83% of the subjects in the NFB group
(P ¼ .089). While this trend is encouraging, it was not reﬂected in
the other patient-reported outcomes at 6 months, with no signiﬁcant difference observed between the groups for the diseasespeciﬁc Knee Injury and Osteoarthritis Outcome Score/Hip
disability and Osteoarthritis Outcome Score subscores (P > .65) or
the EuroQol-5D general health measure (P > .17).
In 2001, a group of surgeons from Europe coined the term
“ERAS” (enhanced recovery after surgery). Their research has
highlighted the focus on the quality of postoperative recovery and
rested on several factors: a multimodal team approach, preoperative counseling, standardized analgesic and anesthetic protocols,
optimization of nutrition, and early mobilization. Paying attention
to these elements they stated: “enhanced recovery after surgery
practices improve the opportunity for rapid, uncomplicated
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Table 5
Patient-Reported Satisfaction for the 2 Groups at 6 mo.
Satisfaction at 6 mo

Feedback Group (N ¼ 80)

No Feedback Group (N ¼ 82)

P

Risk Ratio

95% CI

Satisﬁed or very satisﬁed, N (%)
Same surgery again, N (%)
Knee society satisfaction score, mean/40
Knee society expectation, score/15

73 (91%)
78 (98%)
34.1
10.4 (3.3)

68 (83%)
77 (94%)
33.6
9.9 (2.9)

.089
.230
.691
.308

1.10
1.04

1.0-1.2
1.0-1.1

CI, conﬁdence interval.

recovery after surgery with both short- and long-term beneﬁts for
patients while improving quality and saving money” [23] With the
focus on early mobilization in joint arthroplasty, it has historically
been difﬁcult to monitor postoperative mobility with an objective
scoring system or scale that accurately identiﬁed the patients level
of activity. We believe the use of activity monitors can potentially
lead to improved monitoring and ultimately improved activity
outcomes. Activity monitors have been enthusiastically adopted by
the younger populations. A recent commercial consumer reports of
1000 respondents suggest that over 50% of 18- to 64-year-olds own
at least one wearable device and report health as the primary
motivation for purchase [24]. It is likely that this technology will be
used with increasing frequency in the arthroplasty population of
the future.
Subjects in this study stayed in acute care hospital for a mean of
5 days after arthroplasty. The most common practice was that they
then attended inpatient rehabilitation for a further week. This
practice is considerably slower than the usual care after arthroplasty seen in majority of other centers. This limits the generalizability of our ﬁndings. However, it is plausible that the beneﬁt of
receiving feedback from an activity monitor is relevant to populations of both slow stream and fast stream rehabilitated
protocols.
We identiﬁed some limitations to our study. We question the
accuracy of these activity trackers at low speeds. The devices
make an estimate of daily step count using a combination of
motion sensors, including an accelerometer, which then use an
algorithm to estimate step count. It is the algorithm that allows
the device to differentiate between simple movements of the
arm and walking. It can be expected that the algorithms are
based on “normal” walking speeds and so lack the sensitivity to
accurately measure very slow speed walking or movement patterns that are complicated by use of walking aids, such as
crutches or walking frames. This is especially a concern in the
ﬁrst days after surgery when activity levels are expected to be at
a slower rate [25e27]. This potential error would affect both
groups in this study equally, so should not have unevenly biased
our early results. Regardless, we advocate that these devices are
probably better used after the ﬁrst week from surgery when
walking patterns are starting to normalize. In addition, we lost a
number of patients during our follow-up either due to failure of
device or information loss. We contributed this to possible
hardware or user failure. Overall, the activity monitors were well
tolerated by subjects but for some elderly patients, there were
challenges with successfully managing the technology. Certainly,
setting up the devices correctly required some form of assistance
in a signiﬁcant proportion of these subjects. This is likely to
become less of an issue over time as the younger populations are
vastly more familiar and comfortable with using modern technologies. Finally, during our exclusion process, 30 patients had to
be excluded due to late arrival or delivery of their devices (more
than 1-week postop). Despite these difﬁculties, we achieved a
more than 90% of successful data retrieval of the study cohort
and remained suitably powered for detecting differences in step
counts between the groups.

Conclusion
In a randomized controlled trial, subjects who received feedback
from a commercial activity tracker with a daily step goal had
signiﬁcantly higher activity levels after hip and knee arthroplasty
over 6 months, compared with those who did not receive feedback.
Commercial, noninvasive, light-weight, low-cost accelerometers
may be a useful and effective adjunct to treatment after
arthroplasty.
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